Bruker Corporation to Present at Upcoming Investor Conferences
November 12 2024 - 7:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald
Herman, Executive Vice President & CFO will present on behalf
of the Company at the following investor conferences:
Stifel 2024 Healthcare Conference in New York City
Monday, November 18, 2024, at 8:35 a.m. Eastern Time
Wolfe Research 2024 Healthcare Conference in New York
City Tuesday, November 19, 2024, at 4:10 p.m. Eastern Time
Nasdaq 51st Investor Conference in London, UK Tuesday,
December 10, 2024, at 6:30 a.m. Eastern Time
Live audiovisual webcasts of the presentations will be available
on the Investor Relations section of the Company's website at
https://ir.bruker.com. Replays of the presentations will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the events and will be
available for 90 days following the presentations.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high performance scientific
instruments and high value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241112686671/en/
Joe Kostka Director, Investor Relations Bruker Corporation T: +1
(978) 313-5800 E: Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Nov 2023 to Nov 2024